JOINT CORP/THE (JYNT) Stock Fundamental Analysis
USA - NASDAQ:JYNT - US47973J1025 - Common Stock
7.98 USD
-0.31 (-3.74%)
8.16 USD
+0.18 (+2.26%)
JYNT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 100 industry peers in the Health Care Providers & Services industry. JYNT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. JYNT does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
In the past year JYNT has reported negative net income.
In the past year JYNT had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: JYNT reported negative net income in multiple years.
Each year in the past 5 years JYNT had a positive operating cash flow.
1.2 Ratios
JYNT's Return On Assets of -6.82% is on the low side compared to the rest of the industry. JYNT is outperformed by 71.00% of its industry peers.
With a Return On Equity value of -21.48%, JYNT is not doing good in the industry: 66.00% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.82% | ||
| ROE | -21.48% | ||
| ROIC | N/A |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of JYNT (81.48%) is better than 95.00% of its industry peers.
JYNT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for JYNT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.48% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
2. Health
2.1 Basic Checks
JYNT does not have a ROIC to compare to the WACC, probably because it is not profitable.
JYNT has more shares outstanding than it did 1 year ago.
JYNT has more shares outstanding than it did 5 years ago.
JYNT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 2.83 indicates that JYNT is not a great score, but indicates only limited risk for bankruptcy at the moment.
JYNT has a Altman-Z score of 2.83. This is comparable to the rest of the industry: JYNT outperforms 60.00% of its industry peers.
There is no outstanding debt for JYNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 2.83 |
ROIC/WACCN/A
WACC9.19%
2.3 Liquidity
A Current Ratio of 1.80 indicates that JYNT should not have too much problems paying its short term obligations.
JYNT's Current ratio of 1.80 is fine compared to the rest of the industry. JYNT outperforms 69.00% of its industry peers.
A Quick Ratio of 1.80 indicates that JYNT should not have too much problems paying its short term obligations.
JYNT has a better Quick ratio (1.80) than 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.8 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 72.41% over the past year.
JYNT shows a decrease in Revenue. In the last year, the revenue decreased by -9.68%.
JYNT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.36% yearly.
EPS 1Y (TTM)72.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-56.15%
3.2 Future
The Earnings Per Share is expected to grow by 72.72% on average over the next years. This is a very strong growth
Based on estimates for the next years, JYNT will show a very negative growth in Revenue. The Revenue will decrease by -20.57% on average per year.
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
JYNT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
JYNT is valuated rather expensively with a Price/Forward Earnings ratio of 21.73.
The rest of the industry has a similar Price/Forward Earnings ratio as JYNT.
The average S&P500 Price/Forward Earnings ratio is at 31.86. JYNT is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 21.73 |
4.2 Price Multiples
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JYNT is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 36.21 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
JYNT's earnings are expected to grow with 72.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y91.55%
EPS Next 3Y72.72%
5. Dividend
5.1 Amount
JYNT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
7.98
-0.31 (-3.74%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners77.63%
Inst Owner Change-0.08%
Ins Owners8.65%
Ins Owner Change3.9%
Market Cap122.41M
Revenue(TTM)108.44M
Net Income(TTM)-4.99M
Analysts78.18
Price Target15.17 (90.1%)
Short Float %3.74%
Short Ratio5.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.93%
Min Revenue beat(2)-2.34%
Max Revenue beat(2)-1.53%
Revenue beat(4)1
Avg Revenue beat(4)-12.67%
Min Revenue beat(4)-51.14%
Max Revenue beat(4)4.33%
Revenue beat(8)3
Avg Revenue beat(8)-6.08%
Revenue beat(12)4
Avg Revenue beat(12)-4.64%
Revenue beat(16)6
Avg Revenue beat(16)-3.78%
PT rev (1m)0%
PT rev (3m)-3.25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)-100%
EPS NY rev (1m)0%
EPS NY rev (3m)-107.5%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-3.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.62%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 21.73 | ||
| P/S | 1.13 | ||
| P/FCF | 36.21 | ||
| P/OCF | 25.81 | ||
| P/B | 5.27 | ||
| P/tB | 5.27 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.24
EYN/A
EPS(NY)0.37
Fwd EY4.6%
FCF(TTM)0.22
FCFY2.76%
OCF(TTM)0.31
OCFY3.87%
SpS7.07
BVpS1.51
TBVpS1.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.82% | ||
| ROE | -21.48% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 81.48% | ||
| FCFM | 3.12% |
ROA(3y)-7.05%
ROA(5y)1.52%
ROE(3y)-28.39%
ROE(5y)0.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.87%
GM growth 5Y-2.53%
F-Score6
Asset Turnover1.48
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 52.4% | ||
| Cap/Sales | 1.26% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.8 | ||
| Altman-Z | 2.83 |
F-Score6
WACC9.19%
ROIC/WACCN/A
Cap/Depr(3y)57.36%
Cap/Depr(5y)93.23%
Cap/Sales(3y)6.25%
Cap/Sales(5y)6.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)72.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%53.85%
EPS Next Y98.84%
EPS Next 2Y91.55%
EPS Next 3Y72.72%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.68%
Revenue growth 3Y-13.43%
Revenue growth 5Y1.36%
Sales Q2Q%-56.15%
Revenue Next Year-54.02%
Revenue Next 2Y-28.81%
Revenue Next 3Y-20.57%
Revenue Next 5YN/A
EBIT growth 1Y-162.07%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year313.77%
EBIT Next 3Y73.96%
EBIT Next 5YN/A
FCF growth 1Y-70.37%
FCF growth 3Y6.31%
FCF growth 5Y15.29%
OCF growth 1Y-71.9%
OCF growth 3Y-12.05%
OCF growth 5Y4.6%
JOINT CORP/THE / JYNT FAQ
What is the ChartMill fundamental rating of JOINT CORP/THE (JYNT) stock?
ChartMill assigns a fundamental rating of 3 / 10 to JYNT.
What is the valuation status for JYNT stock?
ChartMill assigns a valuation rating of 3 / 10 to JOINT CORP/THE (JYNT). This can be considered as Overvalued.
How profitable is JOINT CORP/THE (JYNT) stock?
JOINT CORP/THE (JYNT) has a profitability rating of 2 / 10.
Can you provide the expected EPS growth for JYNT stock?
The Earnings per Share (EPS) of JOINT CORP/THE (JYNT) is expected to grow by 98.84% in the next year.